Tag: rhythm pharmaceuticals
August 11, 2019
5 Top Weekly NASDAQ Biotech and Pharma Stocks: Paratek Up 41 Percent
Which biotech and pharma stocks were on the rise last week? We list the top gainers and what may have...
August 7, 2019
Rhythm Pharma Rises on Positive Obesity Trial Results
The company says its lead drug candidate achieved its goals in pivotal Phase 3 trials for rare obesity disorders. August 7, 2019
Rhythm Pharmaceuticals Announces Positive Topline Results from Pivotal Phase 3 Clinical Trials
Rhythm Pharmaceuticals (NASDAQ:RYTM) has announced positive topline results from two Phase 3 clinical trials testing setmelanotide in pro-opiomelanocortin (POMC) and... September 28, 2018
Rhythm Pharmaceuticals Announces Launch of TEMPO Registry for Rare Genetic Disorders of Obesity
Rhythm Pharmaceuticals (NASDAQ:RYTM), a biopharmaceutical company focused on the development and commercialization of therapeutics for the treatment of rare genetic... July 23, 2018
Rhythm Pharmaceuticals Receives European Medicines Agency PRIME Designation for Setmelanotide in Rare Genetic Disorders of Obesity
Rhythm Pharmaceuticals (NASDAQ:RYTM) has announced that the European Agency (EMA) has granted PRIority MEdicines (PRIME) designation for the company’s melanocortin-4... June 14, 2018